Diagnosis Radiothérapie Colorectal cancer Glioblastoma Toxicity Quality of life Microfluidics Prognostic factors Human Humans Bevacizumab DNA repair Chromatin Ovarian cancer Mouse Animals Breast cancer Resistance Autophagy Apoptosis Cytoskeleton Macrophages MRI Biomarkers PARIS team Obesity Leukemia Actin Gene expression Migration Survival Mortality Oncology Prognosis PET Precision medicine Neoplasms Dosimetry Metabolism Ionizing radiation Liver Carcinoma Radiomics Dendritic cells Inflammation Epigenetics Aged Clinical trial Adult France Female Cell migration Classification Surgery Biomarker Hypoxia Male Immune checkpoint inhibitors Cancer du sein Therapy Immunotherapy Radiation therapy Tumor NSCLC Targeted therapy P53 Angiogenesis Cervical cancer Aging COVID-19 Prostate cancer Genomics Deep learning Head and neck cancer Hepatocellular carcinoma Cancer Lung cancer Middle Aged Guidelines Homologous recombination Oxidative stress Chemotherapy Melanoma Treatment Machine learning Lymphoma Artificial intelligence Recurrence Medicine PET/CT Mitochondria Radiotherapy Genetics Overall survival Bladder cancer Metastasis Tumor microenvironment Mutation Transcription Epidemiology